BEGIN:VCALENDAR VERSION:2.0 PRODID:PHP BEGIN:VEVENT DTSTART:20190318 SUMMARY:2019 Keystone Symposia: Epigenetics and Human Disease DESCRIPTION:
On March 18, 2019, Zenith presented a poster at the 2019 Keystone Symposia in Banff, AB: The BET inhibitor ZEN-3694 Blocks Multiple Tumor Immune Suppressive Factors and Has the Potential to Increase the Efficacy of Anti-PD1 Treatment.
END:VEVENT END:VCALENDAR